OFFICIAL PUBLICATION OF

by its subsidiary APPco

Bactroban shortage over

Chris Brooker 30/08/2017

Production issues now resolved, manufacturer tells TGA Manufacturing issues that led to a shortage of the impetigo treatment Bactroban have been resolved, the TGA says. GSK, manufacturer of the treatment has advised that “the shortage of Bactroban (mupirocin) 20 mg/g ointment tube has been resolved”. “Manufacturing issue that resulted in the unavailability of the medicine

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

Bactroban shortage over

Previous "Addiction cannot be cured by a punitive measure."

Next Time out: slapdown for pharmacy radio critic

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous "Addiction cannot be cured by a punitive measure."

Next Time out: slapdown for pharmacy radio critic

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.